Local Transdermal Delivery of Telapristone Acetate Through Breast Skin, Compared With Oral Treatment: A Randomized Double‐Blind, Placebo‐Controlled Phase II Trial-Reference-Cited by-同舟云学术

Local Transdermal Delivery of Telapristone Acetate Through Breast Skin, Compared With Oral Treatment: A Randomized Double‐Blind, Placebo‐Controlled Phase II Trial

Published:2020-10-25 Issue:3 Volume:109 Page:728-738
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Lee Oukseub¹,Pilewskie Melissa²,Karlan Scott³,Tull Mary B.⁴,Benante Kelly¹,Xu Yanfei¹,Blanco Luis⁵,Helenowski Irene⁴,Kocherginsky Masha⁴,Yadav Shivangi¹,Hosseini Omid¹,Hansen Nora¹,Bethke Kevin¹,Muzzio Miguel⁶,Troester Melissa A.⁷,Dimond Eileen⁸,Perloff Marjorie⁸,Heckman‐Stoddard Brandy⁸,Khan Seema A.¹

Affiliation:

1. Department of Surgery Northwestern University Feinberg School of Medicine Chicago Illinois USA

2. Department of Surgery Memorial Sloan Kettering Cancer Center New York New York USA

3. Department of Surgery Cedars‐Sinai Medical Center Los Angeles California USA

4. Department of Preventive Medicine Northwestern University Feinberg School of Medicine Chicago Illinois USA

5. Department of Pathology Northwestern University Feinberg School of Medicine Chicago Illinois USA

6. Analytical Chemistry Division Illinois Institute of Technology Research Institute Chicago Illinois USA

7. Department of Epidemiology University of North Carolina Chapel Hill North Carolina USA

8. National Cancer Institute Division of Cancer Prevention Bethesda Maryland USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2041

Reference36 articles.

1. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

2. Exemestane for Breast-Cancer Prevention in Postmenopausal Women

3. Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

4. Patient Reluctance Toward Tamoxifen Use for Breast Cancer Primary Prevention

5. Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A gel plaster in the form of nipple cover: A comfortable and safe transdermal delivery method for mammary hyperplasia;International Journal of Pharmaceutics;2024-09

2. Antiprogestins for breast cancer treatment: We are almost ready;The Journal of Steroid Biochemistry and Molecular Biology;2024-07

3. A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects;Biomedicine & Pharmacotherapy;2024-02

4. Current status and challenges of breast cancer prevention~DNA methylation would lead to groundbreaking progress in breast cancer prevention~;Genes and Environment;2023-12-12

5. Transdermal therapeutic systems in breast cancer therapy;Journal of Drug Delivery Science and Technology;2023-12